loadpatents
name:-0.017168998718262
name:-0.0094859600067139
name:-0.0014870166778564
Lafleur; David Patent Filings

Lafleur; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lafleur; David.The latest application filed is for "ang-2 binding modular recognition domain complexes and pharmaceutical compositions thereof".

Company Profile
1.8.14
  • Lafleur; David - Washington DC
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Multivalent and monovalent multispecific complexes and their uses
Grant 10,526,381 - Roschke , et al. J
2020-01-07
EGFR-binding modular recognition domains
Grant 10,150,800 - Roschke , et al. Dec
2018-12-11
Polynucleotides encoding angiopoietin-2 (ang-2) binding polypeptides
Grant 10,087,222 - Roschke , et al. October 2, 2
2018-10-02
Ang-2 Binding Modular Recognition Domain Complexes and Pharmaceutical Compositions Thereof
App 20180072783 - ROSCHKE; Viktor ;   et al.
2018-03-15
Multivalent and Monovalent Multispecific Complexes and Their Uses
App 20170298106 - ROSCHKE; Viktor ;   et al.
2017-10-19
Ang-2-binding modular recognition domain complexes and pharmaceutical compositions thereof
Grant 9,676,833 - Roschke , et al. June 13, 2
2017-06-13
Ang-2 Binding Complexes and Uses Thereof
App 20160176934 - ROSCHKE; Viktor ;   et al.
2016-06-23
Multivalent And Monovalent Multispecific Complexes And Their Uses
App 20160046678 - ROSCHKE; Viktor ;   et al.
2016-02-18
Multivalent and Monovalent Multispecific Complexes and Their Uses
App 20150210765 - ROSCHKE; VIKTOR ;   et al.
2015-07-30
Multivalent and Monovalent Multispecific Complexes and Their Uses
App 20140065142 - ROSCHKE; Viktor ;   et al.
2014-03-06
BChE ALBUMIN FUSIONS FOR THE TREATMENT OF COCAINE ABUSE
App 20140065126 - Sklair-Tavron; Liora ;   et al.
2014-03-06
Ang-2 Binding Complexes and Uses Thereof
App 20130259868 - ROSCHKE; Viktor ;   et al.
2013-10-03
BChE albumin fusions for the treatment of cocaine abuse
Grant 8,541,373 - Sklair-Tavron , et al. September 24, 2
2013-09-24
Methods of reducing toxicity and effects of cocaine by administering a butyrylcholinesterase (BChE)-albumin fusion protein
Grant 8,287,859 - Rosen , et al. October 16, 2
2012-10-16
Ang-2 Binding Complexes and Uses Thereof
App 20120100166 - Roschke; Viktor ;   et al.
2012-04-26
Albumin fusion proteins
Grant 8,143,026 - Rosen , et al. March 27, 2
2012-03-27
BChE ALBUMIN FUSIONS FOR THE TREATMENT OF COCAINE ABUSE
App 20110312900 - Sklair-Tavron; Liora ;   et al.
2011-12-22
Albumin Fusion Proteins
App 20110002888 - Rosen; Craig A. ;   et al.
2011-01-06
Albumin Fusion Proteins
App 20080194481 - Rosen; Craig A. ;   et al.
2008-08-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed